首頁 > 市場調查報告書 > 製藥

骨疾病

2030 年亞太地區骨關節炎治療市場預測 - 區域分析 - 按治療類型、疾病適應症和最終用戶

市場調查報告書

商品編碼

1562204

2030 年亞太地區骨關節炎治療市場預測 - 區域分析 - 按治療類型、疾病適應症和最終用戶

Asia Pacific Osteoarthritis Therapy Market Forecast to 2030 - Regional Analysis - by Therapy Type, Disease Indication, and End User

出版日期: 2024年07月04日 | 出版商:

The Insight Partners | 英文 114 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年亞太骨關節炎治療市值為37.0781億美元，預計2030年將達到70.370億美元；預計2022年至2030年複合年成長率為8.3%。

創新治療方案減少對藥物的依賴，推動亞太骨關節炎治療市場的發展

非藥物治療是治療 OA 的關鍵方面。隨著生活方式的改變和藥物的使用，骨關節炎患者可能會受益於各種支持性治療方案，包括熱袋或冷袋以及輔助裝置。此外，營養補充劑和發紅劑等補充和替代療法可能有助於治療骨關節炎。此外，局部治療、監督運動、神經肌肉訓練、自我管理、病患教育和減重介入是最適合骨關節炎的治療方法。

在骨關節炎膝蓋疼痛 (OKP) 治療中，護膝可用於減輕膝蓋疼痛，因為這些護具可以對軟組織施加壓力，穩定膝蓋並重新分配重量。護膝的一些例子是壓縮套、鉸接護膝和卸載護膝。此外，這些壓縮支架可以在藥局、藥局和線上通路輕鬆買到。因此，創新治療方案的可用性減少了對藥物的依賴，從而推動了骨關節炎治療市場的成長。

亞太地區骨關節炎治療市場概況

亞太地區骨關節炎治療市場分為中國、日本、印度、澳洲、韓國和亞太其他國家。患者是否有能力進行臨床試驗來測試治療骨關節炎的藥物是預測期內市場成長的最有影響力的因素。此外，政府對進行患者臨床試驗的支持進一步促進了未來幾年的市場成長。根據Frontiers SA的報告，在中國人口老化負擔沉重的情況下，膝關節骨關節炎是導致殘疾的主要原因，給中國人口帶來了巨大的醫療費用負擔。此外，美國國立衛生研究院(NIH) 報告稱，在中國農村地區，有症狀的膝關節OA 更為普遍（16.57%），並且這種發病率在70 歲及以上人群中顯著增加（女性為29.25%，男性為24.71%）。因此，中藥(TCM) 已被接受為膝關節OA 的補充療法。。非藥物選擇包括病患教育、職業和物理治療、有氧運動、社會支持和減重。此外，中國人群的膝關節骨關節炎透過藥物療法進行治療，例如單純鴉片類鎮痛藥、非類固醇類抗發炎藥物（NSAID）（包括COX-2選擇性抑制劑）以及注射劑（例如糖皮質激素和透明質酸製劑）。因此，中國老齡化人口中膝骨關節炎盛行率的上升加速了對創新治療方案的需求，主導了2022-2030年的市場成長。

亞太地區骨關節炎治療市場收入及 2030 年預測（百萬美元）

亞太地區骨關節炎治療市場區隔

亞太地區骨關節炎治療市場按治療類型、疾病適應症、最終用戶和國家分類。

依治療類型，亞太地區骨關節炎治療市場分為經皮神經電刺激（TENS）、職能治療、物理治療、富血小板血漿（PRP）治療及基質血管成分、增生療法等。 2022 年，物理治療領域佔據最大的市場。

從疾病適應症來看，亞太骨關節炎治療市場分為膝骨關節炎、脊椎骨關節炎、足踝骨關節炎、肩骨關節炎、手骨關節炎等。 2022年，膝骨關節炎細分市場佔據亞太骨關節炎治療市場的最大佔有率。

根據最終用戶，亞太地區骨關節炎治療市場分為醫院和診所、專科診所、門診手術中心、家庭護理等。 2022 年，家庭護理領域佔據亞太骨關節炎治療市場的最大佔有率。

依國家/地區分類，亞太地區骨關節炎治療市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022年，中國在亞太骨關節炎治療市場佔有率中佔據主導地位。

Zimmer Biomet Holdings Inc、DePuy Synthes Inc、Bioventus Inc、Omron Healthcare Inc、Exactech Inc、Medi GmbH & Co KG 和 Zealmax Innovations Pvt Ltd 是亞太骨關節炎治療市場上的一些領先公司。

The non-pharmacologic therapy is a key facet of treating OA. With lifestyle changes and medicines, patients suffering from OA may benefit from various supportive therapy options, including hot or cold packs and assistive devices. Additionally, complementary, and alternative therapy options such as nutritional supplements and rubefacients may help in managing OA. Further, topical treatments, supervised exercises, neuromuscular training, self-management, patient education, and weight loss intervention are among the best treatments suited for OA.

In osteoarthritis knee pain (OKP) treatment, knee braces are used to reduce knee pain as these braces may apply compression (pressure) to soft tissues, stabilize the knee, and redistribute weight. A few examples of knee braces are compression sleeves, hinged knee braces, and unloader knee braces. Also, these compression braces are easily available at drugstores, pharmacies, and online channels. Therefore, availability of innovative therapy options reduces dependency on medications, which drives the osteoarthritis therapy market growth.

Asia Pacific Osteoarthritis Therapy Market Overview

Asia Pacific osteoarthritis therapy market is segmented as China, Japan, India, Australia, South Korea, and Rest of Asia Pacific countries. The patients availability for conducting clinical trials to test drugs intended for osteoarthritis is the most influential factors responsible for market growth during the forecast period. Also, government support for conducting the patient's clinical trials further enhances the market growth during the coming years. According to the Frontiers S.A. report, with China having a high burden of an aging population, knee O.A. is the leading cause of disability, having a burden of huge healthcare costs among the Chinese population. Additionally, the National Institute of Health (NIH) reports that in rural China, symptomatic knee O.A. is more prevalent (16.57%), and this incidence has increased significantly among the population aged 70 years and older (29.25% among women and 24.71% among men). Therefore, traditional Chinese medicines (TCM) have been accepted as a complementary therapy for knee O.A. For example, acupuncture and Tai Chi are non-surgical treatment options for knee O.A. Additionally, non-pharmacological treatment options to treat knee O.A. in China emphasize a multidisciplinary approach to reduce pain and disability among the Chinese population. Non-pharmacological options include patient education, occupational and physical therapy, aerobic exercises, social support, and weight loss. Also, knee O.A. among the Chinese population is treated by pharmacological therapies such as simple and opioid analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), including COX-2 selective inhibitors, and injectable agents such as glucocorticoids and hyaluronan preparations. Therefore, the rising prevalence of knee O.A. among the aging Chinese population accelerates demand for innovative therapy options, dominating the market growth during the 2022-2030.

Asia Pacific Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Osteoarthritis Therapy Market Segmentation

The Asia Pacific osteoarthritis therapy market is categorized into therapy type, disease indications, end user, and country.

Based on therapy type, the Asia Pacific osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share in 2022.

In terms of disease indications, the Asia Pacific osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of Asia Pacific osteoarthritis therapy market in 2022.

Based on end user, the Asia Pacific osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held the largest share of Asia Pacific osteoarthritis therapy market in 2022.

By country, the Asia Pacific osteoarthritis therapy market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific osteoarthritis therapy market share in 2022.

Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc, Medi GmbH & Co KG, and Zealmax Innovations Pvt Ltd are some of the leading companies operating in the Asia Pacific osteoarthritis therapy market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

4.1 Pipeline Analysis
- 4.1.1 Clinical Trial Pipeline Analysis

5. Asia Pacific Osteoarthritis Therapy Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Osteoarthritis
- 5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
- 5.2.1 Product Recall
5.3 Market Opportunities
- 5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
- 5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - Asia Pacific Market Analysis

6.1 Overview
- 6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

7. Asia Pacific Osteoarthritis Therapy Market Analysis - by Therapy Type

7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
- 7.2.1 Overview
- 7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
- 7.3.1 Overview
- 7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
- 7.4.1 Overview
- 7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
- 7.5.1 Overview
- 7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
- 7.6.1 Overview
- 7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Osteoarthritis Therapy Market Analysis - by Disease Indication

8.1 Overview
8.2 Knee Osteoarthritis
- 8.2.1 Overview
- 8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
- 8.3.1 Overview
- 8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
- 8.4.1 Overview
- 8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
- 8.5.1 Overview
- 8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
- 8.6.1 Overview
- 8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Osteoarthritis Therapy Market Analysis - by End User

9.1 Overview
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
- 9.5.1 Overview
- 9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Osteoarthritis Therapy Market - Country Analysis

10.1 Asia Pacific Market Overview
- 10.1.1 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 China: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.1.4 China: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.1.5 China: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Japan: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.2.4 Japan: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.2.5 Japan: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.3 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 India: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.3.4 India: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.3.5 India: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.4 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Australia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.4.4 Australia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.4.5 Australia: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.5 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 South Korea: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.5.4 South Korea: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.5.5 South Korea: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.6 Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Asia Pacific: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.6.4 Rest of Asia Pacific: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.6.5 Rest of Asia Pacific: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 Zimmer Biomet Holdings Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 DePuy Synthes Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Bioventus Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Omron Healthcare Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Exactech Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Medi GmbH & Co KG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Zealmax Innovations Pvt Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About the Insight Partners

簡介目錄圖表

List Of Tables

Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 13. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 14. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 16. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 17. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 18. Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 19. Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 20. Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Organic Developments Done by Companies
Table 22. Inorganic Developments Done by Companies

List Of Figures

Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Asia Pacific: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)
Figure 26. Asia Pacific: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Growth Strategies in the Osteoarthritis Therapy Market